South Korea Insulin Delivery Devices Market Overview, 2031

Diabetes has been on the rise ly, and South Korea is no exception. An increasing number of people diagnosed with diabetes leads to a higher demand for insulin and related delivery devices. South Korea has an aging population, and diabetes is more prevalent among older individuals. As the population ages, the incidence of diabetes tends to increase, driving the demand for insulin and associated delivery devices. The continuous advancement in insulin delivery device technology has likely contributed to the market growth. Newer devices that offer better precision ease of use, and improved patient outcomes may be gaining popularity. Efforts to raise awareness about diabetes and its management, as well as educating both healthcare professionals and patients about the importance of proper insulin delivery, could be playing a role in the growth of the market. A well-developed healthcare system that supports the management of chronic conditions like diabetes, including access to insulin and related devices, can contribute to market growth. Improved access to healthcare services, including diabetes diagnosis, treatment, and management, can contribute to the growth of the insulin delivery devices market. If more individuals have access to healthcare facilities and can afford necessary treatments, the demand for insulin and delivery devices is likely to increase. The growing emphasis on patient empowerment and self-care may be driving individuals with diabetes to actively manage their condition. Insulin delivery devices that empower patients to take control of their treatment may see increased adoption. The integration of digital health technologies and connectivity features in insulin delivery devices may attract tech-savvy individuals. Devices that offer features such as data tracking, remote monitoring, and connectivity with mobile apps could see increased demand.

According to the research report, " South Korea Insulin Delivery Devices Market Overview, 2031," published by Bonafide Research, the South Korea Insulin Delivery Devices market is expected to reach a market size of more than USD 1.24 Billion by 2031. The insulin delivery devices market has seen continuous technological advancements. This includes the development of smart insulin pens, insulin pumps with integrated continuous glucose monitoring CGM systems, and other connected devices. These technologies aim to enhance precision, ease of use, and patient adherence. Integration with digital health platforms and mobile applications is becoming increasingly common. These features enable users to track insulin dosages, monitor glucose levels, and share data with healthcare providers. The integration of digital solutions aims to improve diabetes management and patient outcomes. Connectivity features in insulin delivery devices, such as Bluetooth and Wi-Fi capabilities, enable remote monitoring by healthcare providers and caregivers. This trend aligns with the broader movement towards telemedicine and remote healthcare management. The integration of artificial intelligence in diabetes management is a growing trend. AI can analyse patient data, predict glucose patterns, and provide personalized recommendations for insulin dosing. Insulin delivery devices with AI capabilities may gain traction as technology continues to advance. Closed-loop insulin delivery systems, also known as artificial pancreas systems, are gaining attention. These systems automatically adjust insulin delivery based on real-time glucose monitoring, providing a more automated and responsive approach to diabetes management. The integration of insulin delivery devices with mobile health applications continues to grow. These apps can assist users in tracking blood glucose levels, managing insulin doses, and providing educational resources.

South Korea insulin delivery devices market by product types is divided into insulin pens, insulin pump, insulin syringes and other insulin delivery services. In South Korea, the market for insulin delivery devices is divided into categories including insulin pens, insulin pumps, insulin syringes, and various other delivery methods, which cater to a range of patient requirements and the increasing need for convenient diabetes management options. Insulin pens stand out as the most prominent and established device type, dominating the market share due to their simplicity of use, ease of transport, and accurate dosing capabilities. Their acceptance is on the rise among Type 1 and Type 2 diabetes patients, particularly in an aging population and with the growing use of digital health tools that assist with tracking doses and improving adherence. Insulin pumps are the quickest expanding segment within the South Korean market, driven by advancements in technologies for continuous subcutaneous insulin infusion CSII, integration with glucose monitoring devices, and an increased focus on achieving better glycemic control for patients needing intensive insulin regimens. Although they are currently less prevalent than pens, innovative pumps including those that are tubeless and wearable are gaining traction among tech-savvy users, buoyed by recent product introductions and the development of smart connectable devices. Insulin syringes remain essential for patients who prefer economical and simple delivery options, especially where the adoption of advanced devices is slower. Emerging other delivery systems, such as needle-free injectors or smart wearable patches, are still in their early stages but contribute to the future range of delivery choices available in the country.

South Korea insulin delivery devices market by disease types is divided into type 1 and type 2. The landscape of insulin delivery devices in South Korea is also shaped by the unique needs of individuals with Type 1 and Type 2 diabetes, which affects preferences for devices and their usage patterns. Type 2 diabetes represents the majority of cases in South Korea, similar to trends seen driven by aging populations, lifestyle choices, and urban eating habits; many Types 2 diabetes patients begin insulin therapy later in their treatment journey and often choose insulin pens and syringes due to their suitability for intermittent dosing and routine self-management. This wider patient demographic helps maintain strong demand for easy-to-use pen devices in outpatient settings and home care. Conversely, patients with Type 1 diabetes who need insulin therapy continuously from the time of diagnosis are the main users of advanced delivery technologies like insulin pumps, which allow for continuous and accurate insulin delivery, potentially bettering glycemic control and quality of life. The uptake of pump systems, although historically lower in South Korea compared to some Western regions due to issues such as cost, education, and reimbursement challenges, is gradually increasing as newer automated features and clinical backing generate interest among both patients and endocrinologists. These disease categories influence the direction of product development and market growth, balancing the demand for both standard and innovative delivery solutions that address specific medical needs.

South Korea insulin delivery devices market by end user is divided into home care setting, hospitals and clinics and other end users. When categorized by end users, the market for insulin delivery devices in South Korea is primarily led by home care environments, which align with larger healthcare trends that promote self-management of long-term conditions such as diabetes. Most individuals using insulin handle their treatment at home with the help of pens and increasingly with pumps, highlighting the significance of user-friendliness, patient independence, and the incorporation of digital tools for daily dosing and glucose monitoring. Consequently, manufacturers and healthcare professionals focus on creating devices that are easy to use, dependable, and complemented by education and follow-up care to encourage sustained usage outside of clinical settings. Hospitals and clinics represent another essential category, especially during diagnosis, starting therapy, urgent care, and when patients shift to advanced technologies such as insulin pumps, which need clinical setup, supervision, and patient instruction. In these environments, healthcare specialists are vital in choosing devices, educating patients, adjusting dosages, and offering assistance particularly for individuals with complicated requirements or new to insulin therapy. Other end users, including specialized diabetes centers and long-term care institutions, account for a smaller yet significant share of device use, especially for patients needing ongoing clinical supervision or those with other health conditions. The market in South Korea shows a lively interaction between home-based self-management and organized clinical treatment, supported by a national healthcare system and changing insurance coverage that collectively affect the selection and usage of insulin delivery devices.



"Considered in this report
• Historic Year: 2020
• Base year: 2025
• Estimated year: 2026
• Forecast year: 2031
Aspects covered in this report
• Insulin Delivery Devices Market with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

By product Types
• Insulin Pens
• Insulin Pump
• Insulin Syringes
• Others Insulin Delivery Devices

By Disease Types
• Type 1
• Type 2

By End User
• Home care setting
• Hospitals & clinics
• Others End users “